Literature DB >> 16601750

The complexity of p53 stabilization and activation.

M F Lavin1, N Gueven.   

Abstract

A number of proteins are activated by stress stimuli but none so spectacularly or with the degree of complexity as the tumour suppressor p53 (human p53 gene or protein). Once stabilized, p53 is responsible for the transcriptional activation of a series of proteins involved in cell cycle control, apoptosis and senescence. This protein is present at low levels in resting cells but after exposure to DNA-damaging agents and other stress stimuli it is stabilized and activated by a series of post-translational modifications that free it from MDM2 (mouse double minute 2 but used interchangeably to denote human also), a ubiquination ligase that ubiquitinates it prior to proteasome degradation. The stability of p53 is also influenced by a series of other interacting proteins. In this review, we discuss the post-translational modifications to p53 in response to different stresses and the consequences of these changes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601750     DOI: 10.1038/sj.cdd.4401925

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  240 in total

Review 1.  Using mice to examine p53 functions in cancer, aging, and longevity.

Authors:  Lawrence A Donehower
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11-04       Impact factor: 10.005

Review 2.  Driving apoptosis-relevant proteins toward neural differentiation.

Authors:  Susana Solá; Márcia M Aranha; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2012-07-01       Impact factor: 5.590

3.  Substrate phosphorylation and feedback regulation in JFK-promoted p53 destabilization.

Authors:  Luyang Sun; Lei Shi; Feng Wang; Peiwei Huangyang; Wenzhe Si; Jie Yang; Zhi Yao; Yongfeng Shang
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

4.  Characterization of Human Homeodomain-interacting Protein Kinase 4 (HIPK4) as a Unique Member of the HIPK Family.

Authors:  Qin He; Jingxue Shi; Hong Sun; Jie An; Ying Huang; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2010

5.  Induction of SOX4 by DNA damage is critical for p53 stabilization and function.

Authors:  Xin Pan; Jie Zhao; Wei-Na Zhang; Hui-Yan Li; Rui Mu; Tao Zhou; Hai-Ying Zhang; Wei-Li Gong; Ming Yu; Jiang-Hong Man; Pei-Jing Zhang; Ai-Ling Li; Xue-Min Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

6.  Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation.

Authors:  Sanjeev Das; Lakshmi Raj; Bo Zhao; Yuki Kimura; Alan Bernstein; Stuart A Aaronson; Sam W Lee
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

7.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

8.  The baculovirus sulfhydryl oxidase Ac92 (P33) interacts with the Spodoptera frugiperda P53 protein and oxidizes it in vitro.

Authors:  Wenbi Wu; Rollie J Clem; George F Rohrmann; A Lorena Passarelli
Journal:  Virology       Date:  2013-10-01       Impact factor: 3.616

9.  Partial p53-dependence of anisomycin-induced apoptosis in PC12 cells.

Authors:  R Schipp; J Varga; J Bátor; M Vecsernyés; Z Árvai; M Pap; József Szeberényi
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

10.  Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells.

Authors:  R Barzalobre-Gerónimo; Barzalobre-Gerónimo Raúl; L A Flores-López; Flores-López Luis Antonio; L A Baiza-Gutman; Baiza-Gutman Luis Arturo; M Cruz; Cruz Miguel; R García-Macedo; García-Macedo Rebeca; A Ávalos-Rodríguez; Ávalos-Rodríguez Alejandro; A Contreras-Ramos; Contreras-Ramos Alejandra; A Díaz-Flores; Díaz-Flores Margarita; C Ortega-Camarillo; Ortega-Camarillo Clara
Journal:  Mol Cell Biochem       Date:  2015-04-28       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.